Health ❯Medicine ❯Neurology

Cognitive Disorders

Amyloid Protein Chemo Brain Dementia Symptoms Mild Cognitive Impairment

Valacyclovir Shows No Benefit in Early Alzheimer’s Phase II Trial

Trial results indicate that valacyclovir offers no cognitive benefit or biomarker changes despite its safety profile

Ambroxol Demonstrates Safety and Neuroprotection Signals in Parkinson’s Dementia Trial

Study Suggests Long-Term Anti-Amyloid Therapy May Delay Early-Onset Alzheimer’s

MIT's Noninvasive Therapy Shows Promise Against Chemo Brain